Drugs
2
in active trials
Trials
2 active
2 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Radiation-Induced Xerostomia and Hyposalivation | ||||
| Open drug page | |||||
In vivo CD19 CAR, circular RNA in targeted lipid nanoparticles |
Phase 1 | 19 Dec 2027Early Phase 1 trial completes | |||
| How it works | Reprograms the patient's own immune T cells | ||||
| Next date | 19 Dec 2027 · Early Phase 1 trial completes | ||||
| Also tested for | Relapsed/Refractory B Cell-Mediated Autoimmune Diseases, Immune Thrombocytopenia (ITP) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev